The Essential Tremor (ET) and Parkinson Disease (PD) Tremor Acute Stimulation Study
The Essential Tremor (ET) and Parkinson Disease (PD) Tremor Acute Stimulation Study
The current study is designed to test the hypothesis that targeted electrical stimulation
 will result in upper limb tremor reduction in ET and PD patients.
This study will evaluate the effect of Rainbow Medical's stimulation procedure methodology
 that will be applied temporarily to patients suffering of tremor.

 This will be evaluated by assessment of reduction of tremor using accelerometer measurements,
 patient tremor evaluation diary, tremor rating scale, and the Unified Parkinson's Disease
 Rating Scale (UPRDS) part III.In addition,tasks for patient with tremor will be conducted
 before during and after the treatment. The above measurements will provide data on the
 stimulation procedure effect as compared to baseline.
Inclusion Criteria:

 -  Able to Sign written informed consent in Hebrew.

 -  Patient agrees to attend all treatment procedures and follow-up evaluations and is
 willing and able to comply with all study requirements.

 -  Patient with a clinical diagnosis of idiopathic PD, or ET for more than 3 years.

 -  Significant tremor for at least one upper limb causing distress or disability.

 -  Patient should be stable on anti-Parkinson's disease or anti-tremor medication for at
 least one month prior to study enrollment.

 Exclusion Criteria:

 -  Previous participation in another study with any investigational drug or device within
 the past 90 days.

 -  Any active implant (cardiac or other).

 -  Current pregnancy or attempting to get pregnant (female patient).

 -  Patient has any major illness or medical condition that in the opinion of the
 physician would interfere with participation in the study.

 -  Patient with other significant neurological or psychiatric disease other than
 Parkinson Disease or Essential Tremor.

 -  Patient has any other condition expect for PD and ET that induce tremor.

 -  Patient is treated with drug that may induce tremor.

 -  Patient abuses drugs or alcohol.

 -  Any previous thalamotomy, pallidotomy or patient who has undergone a DBS procedure.

 -  Any anticipated need for surgery during the study.

 -  Any malignancy in the past 2 years.

 -  Patient has confirmation of diagnosis of a terminal illness associated with survival
 <12 months.